Cite

HARVARD Citation

    Freeman, M. et al. (n.d.). Results from a phase 1 multiple ascending dose study demonstrating safety and selectivity of aldosterone synthase inhibitor CIN-107. European heart journal. p. . [Online]. 
  
Back to record